Triple combinations in chronic obstructive pulmonary disease – is three better than two?
Authors:
- Mario CazzolaMCMario Cazzola
- Maria Gabriella MateraMMMaria Gabriella Matera
- 18 October 2014
- journal article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 15 (17) , 2475-2478
Abstract
A growing body of evidence suggests that triple therapy with an antimuscarinic agent, a long-acting β2-agonist, and an inhaled corticosteroid is efficacious in patients with more severe chronic obstructive pulmonary disease (COPD), such as those with frequent exacerbations. Moreover, this therapy is often prescribed in real-life management of COPD, even in patients who are not suffering from severe COPD. All this makes triple therapy an attractive therapeutic approach. Therefore, a variety of triple combinations are currently under development. However, there are a number of issues that need to be addressed in order to optimize the use of triple therapy in COPD because data are still too scarce and studies too short to generate a strong recommendation.Keywords
This publication has 19 references indexed in Scilit:
- Treatment Evolution after COPD Diagnosis in the UK Primary Care SettingPLOS ONE, 2014
- Trends in management and outcomes of COPD patients in primary care, 2000–2009: a retrospective cohort studynpj Primary Care Respiratory Medicine, 2014
- Impact of Long-Acting Bronchodilators and Exposure to Inhaled Corticosteroids on Mortality in COPD: A Real-Life Retrospective Cohort StudyLung, 2014
- Benefits of adding fluticasone propionate/salmeterol to tiotropium in COPD: A meta-analysisEuropean Journal of Internal Medicine, 2014
- BronchodilatorsClinics in Chest Medicine, 2014
- Effects of Tiotropium and Salmeterol/Fluticasone Propionate on Airway Wall Thickness in Chronic Obstructive Pulmonary DiseaseRespiration, 2013
- How far is real life from COPD therapy guidelines? An Italian observational studyRespiratory Medicine, 2012
- Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: A systematic reviewPulmonary Pharmacology & Therapeutics, 2012
- Comparative effectiveness of drugs for chronic obstructive pulmonary diseaseDrugs of Today, 2012
- Triple Therapy for the Management of COPD: A ReviewCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2011